Novel proteasome inhibitors targeting both beta5 and beta2 subunits for treatment of triple negative breast cancer Grant

Overview

date/time interval

February 22, 2024 - December 31, 2028

awarded by

National Cancer Institute

administered by

Microbiology and Immunology

sponsor award ID

1 R01 CA276053-01A1

Affiliation

contributor

Lin, Gang Principal Investigator 2024 - 2028
Ma, Xiaojing Co-Principal Investigator 2024 - 2028